NCT06625775 2026-03-18
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Phase 1 Recruiting
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Federation Francophone de Cancerologie Digestive
Genentech, Inc.
Pfizer
AstraZeneca